Cardiac transplantation in muscular dystrophies: A case series

被引:0
作者
Bergier, Mariano G. [1 ]
Blanco, Rocio [1 ]
Lillo, Ezequiel [1 ]
Posatini, Ricardo [2 ]
Belziti, Cesar A. [1 ]
机构
[1] Hosp Italiano Buenos Aires, Cardiol Dept, Buenos Aires, Argentina
[2] Hosp Italiano Buenos Aires, Cardiovasc Surg Dept, Buenos Aires, Argentina
关键词
Cardiac transplantation; Muscular dystrophy; Cardiomyopathy; Genetics; INVOLVEMENT;
D O I
10.1016/j.cpcardiol.2025.102997
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Muscular dystrophies can involve cardiac complications, including dilated cardiomyopathy, arrhythmias, and conduction system disorders. In cases of terminal heart failure, cardiac transplantation may be considered a viable option; however, its feasibility in this population has been questioned for many years. This case series describes the preoperative characteristics and postoperative outcomes of five patients with muscular dystrophy and dilated cardiomyopathy who underwent cardiac transplantation at a tertiary care center in Latin America between 2018 and 2024. All patients were male, with a mean age of 38.4 +/- 11.5 years at transplantation. Genetic variants were confirmed in all cases. Although two patients experienced postoperative respiratory and swallowing complications, survival was 100 %, with a median follow-up of 16 months and good functional capacity. Cardiac transplantation is a valid option for patients with muscular dystrophies and dilated cardiomyopathy, emphasizing the importance of functional evaluation and a multidisciplinary approach to optimize outcomes.
引用
收藏
页数:5
相关论文
共 9 条
  • [1] Management of Cardiac Involvement Associated With Neuromuscular Diseases A Scientific Statement From the American Heart Association
    Feingold, Brian
    Mahle, William T.
    Auerbach, Scott
    Clemens, Paula
    Domenighetti, Andrea A.
    Jefferies, John L.
    Judge, Daniel P.
    Lal, Ashwin K.
    Markham, Larry W.
    Parks, W. James
    Tsuda, Takeshi
    Wang, Paul J.
    Yoo, Shi-Joon
    [J]. CIRCULATION, 2017, 136 (13) : E200 - E231
  • [2] Martins IQ, 2023, REV ESP ANEST REANIM, V70, P540, DOI [10.1016/j.redar.2022.11.006, 10.1016/j.redare.2023.09.008]
  • [3] Papa AA, 2017, INTRACTABLE RARE DIS, V6, P95, DOI 10.5582/irdr.2017.01024
  • [4] Is Cardiac Transplantation Still a Contraindication in Patients with Muscular Dystrophy-Related End-Stage Dilated Cardiomyopathy? A Systematic Review
    Politano, Luisa
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [5] Posada Rodriguez I J, 1997, Rev Esp Cardiol, V50, P882
  • [6] NEUROMUSCULAR DISEASE AND ANESTHESIA
    Romero, Alan
    Joshi, Girish P.
    [J]. MUSCLE & NERVE, 2013, 48 (03) : 451 - 460
  • [7] Heart Transplantation Ameliorates Ambulation Capacity in Patients With Muscular Dystrophy - An Analysis of 9 Cases -
    Seguchi, Osamu
    Kuroda, Kensuke
    Fujita, Tomoyuki
    Kumai, Yuto
    Nakajima, Seiko
    Watanabe, Takuya
    Yanase, Masanobu
    Matsumoto, Yorihiko
    Fukushima, Satsuki
    Kimura, Koichi
    Fukushima, Norihide
    [J]. CIRCULATION JOURNAL, 2019, 83 (03) : 684 - +
  • [8] Heart Transplantation in Muscular Dystrophy Patients Is it a Viable Option?
    Wells, Dennis
    Rizwan, Raheel
    Jefferies, John L.
    Bryant, Roosevelt, III
    Ryan, Thomas D.
    Lorts, Angela
    Chin, Clifford
    Zafar, Farhan
    Morales, David L.
    [J]. CIRCULATION-HEART FAILURE, 2020, 13 (04) : E005447
  • [9] Clinical outcomes after cardiac transplantation in muscular dystrophy patients
    Wu, Roland S.
    Gupta, Sachin
    Brown, Robert N.
    Yancy, Clyde W.
    Wald, Joyce W.
    Kaiser, Patricia
    Kirklin, Nicole M.
    Patel, Parag C.
    Markham, David W.
    Drazner, Mark H.
    Garry, Daniel J.
    Mammen, Pradeep P. A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (04) : 432 - 438